BioSpace News Archive

COVAX is the global initiative that will make COVID-19 vaccines available for 190 countries, including the poorest in the world

Anitoa Systemc, LLC., market leader in rapid, portable PCR-based molecular testing, today announced the award of CE (Conformité Européene)-IVD Mark for its Maverick series portable qPCR instruments. The CE Mark confirms that the Company’s Maverick series products meet the requirements of the European In-Vitro Diagnostic Device

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19

Aytu BioScience, Inc. (NASDAQ:AYTU), , a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today the closing of its previously announced underwritten public offering of 4,791,667 shares of common stock of the Company, which includes the full exercise of the underwriters option to purchase an additional 625,000 shares

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro’s Chairman, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference

Apollo Endosurgery, Inc. (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today U.S. Food and Drug Administration 510k clearance of the X-Tack; Endoscopic HeliX Tacking System. X-Tack is a new, through-the-scope, suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract